Gastrointestinal organs and organoids-on-a-chip: advances and translation into the clinics
Microfluidic organs and organoids-on-a-chip models of human gastrointestinal systems
have been established to recreate adequate microenvironments to study physiology and …
have been established to recreate adequate microenvironments to study physiology and …
[HTML][HTML] Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations
ZN Abbas, AZ Al-Saffar, SM Jasim, GM Sulaiman - Scientific Reports, 2023 - nature.com
Drug development is a time-consuming and expensive process, given the low success rate
of clinical trials. Now, anticancer drug developments have shifted to three-dimensional (3D) …
of clinical trials. Now, anticancer drug developments have shifted to three-dimensional (3D) …
Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis
AL Caipa Garcia, VM Arlt, DH Phillips - Mutagenesis, 2022 - academic.oup.com
Advances in three-dimensional (3D) cell culture technology have led to the development of
more biologically and physiologically relevant models to study organ development, disease …
more biologically and physiologically relevant models to study organ development, disease …
Exploring the anti-metastatic effects of Astragalus mongholicus Bunge-Curcuma aromatica Salisb. on colorectal cancer: A network-based metabolomics and …
ZQ Liang, Y Bian, JF Gu, G Yin, RL Sun, Y Liang… - Phytomedicine, 2023 - Elsevier
Background Colorectal cancer (CRC) is a common malignancy that can significantly
diminish patients' quality of life. Astragalus mongholicus Bunge-Curcuma aromatica …
diminish patients' quality of life. Astragalus mongholicus Bunge-Curcuma aromatica …
Inhibitory effects of peroxidase from foxtail millet bran on colitis-associated colorectal carcinogenesis by the blockage of glycerophospholipid metabolism
S Shan, C Wu, J Shi, X Zhang, J Niu… - Journal of agricultural …, 2020 - ACS Publications
Abnormal glycerophospholipid (GPL) metabolism represented by phosphatidylcholine (PC)
and phosphatidylethanolamine (PE) has been as a universal metabolic hallmark of cancer …
and phosphatidylethanolamine (PE) has been as a universal metabolic hallmark of cancer …
[HTML][HTML] eIF4E S209 phosphorylation licenses myc-and stress-driven oncogenesis
To better understand a role of eIF4E S209 in oncogenic translation, we generated
EIF4ES209A/+ heterozygous knockin (4EKI) HCT 116 human colorectal cancer (CRC) cells …
EIF4ES209A/+ heterozygous knockin (4EKI) HCT 116 human colorectal cancer (CRC) cells …
[HTML][HTML] Amino acid transporters on the guard of cell genome and epigenome
Simple Summary Amino acid transporters play a multifaceted role in tumor initiation,
progression, and therapy resistance. They are critical to cover the high energetic and …
progression, and therapy resistance. They are critical to cover the high energetic and …
Reconstructing the tumor architecture into organoids
Cancer remains a leading health burden worldwide. One of the challenges hindering cancer
therapy development is the substantial discrepancies between the existing cancer models …
therapy development is the substantial discrepancies between the existing cancer models …
Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro
A Skirzynska, C Xue, MS Shoichet - Advanced Materials, 2024 - Wiley Online Library
Engineered biomaterial scaffolds are becoming more prominent in research laboratories to
study drug efficacy for oncological applications in vitro, but do they have a place in …
study drug efficacy for oncological applications in vitro, but do they have a place in …
[HTML][HTML] Patient-derived xenograft vs. organoids: a preliminary analysis of cancer research output, funding and human health impact in 2014–2019
LJ Marshall, M Triunfol, T Seidle - Animals, 2020 - mdpi.com
Simple Summary Given ongoing issues with public opinion against the use of animals in
biomedical research, scant research resources, high drug costs, low translational success …
biomedical research, scant research resources, high drug costs, low translational success …